CAS 1186206-79-0

Formel: C32H32F3N5O2S

InChl: InChI=1S/C32H32F3N5O2S/c1-3-39-10-12-40(13-11-39)20-23-8-9-26(17-27(23)32(33,34)35)37-30(41)22-7-6-21(2)28(16-22)38-31(42)25-15-24(18-36-19-25)29-5-4-14-43-29/h4-9,14-19H,3,10-13,20H2,1-2H3,(H,37,41)(H,38,42)

InChI Key: HYWXBDQAYLPMIX-UHFFFAOYSA-N

SMILES: CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)NC(=O)C4=CN=CC(=C4)C5=CC=CS5)C(F)(F)F

ALW-II-41-27

CAS: 1186206-79-0

ALW-II-41-27

Formel: C₃₂H₃₂F₃N₅O₂S

Reinheit: 99.5%

Molekulargewicht: 607.69

Ref: 54-BUP05606

N-(5-((4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)carbamoyl)-2-methylphenyl)-5-(thiophen-2-yl)nicotinamide

CAS: 1186206-79-0

Formel: C₃₂H₃₂F₃N₅O₂S

Reinheit: 99%

Molekulargewicht: 607.69

Ref: IN-DG629962

ALW-II-41-27

CAS: 1186206-79-0

ALW-II-41-27 (Eph receptor tyrosine kinase inhibitor), an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.

Formel: C₃₂H₃₂F₃N₅O₂S

Reinheit: 97.01% - 99.52%

Farbe und Form: Yellow Solid

Molekulargewicht: 607.689

Ref: TM-T4344

BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]-

CAS: 1186206-79-0

Reinheit: 98%

Molekulargewicht: 607.7000122

Ref: 10-F863224

BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]-

CAS: 1186206-79-0

Formel: C₃₂H₃₂F₃N₅O₂S

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 607.6890

Ref: IN-DA008TDD

ALW-II-41-27 - Bio-X ™

CAS: 1186206-79-0

This product is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

Formel: C₃₂H₃₂F₃N₅O₂S

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 607.69 g/mol

Ref: 3D-BA300006

ALW-II-41-27

CAS: 1186206-79-0

LW-II-41-27 is a novel Eph receptor tyrosine kinase inhibitor used for cancer treatment.

Formel: C₃₂H₃₂F₃N₅O₂S

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 607.69 g/mol

Ref: 3D-BA164807